Showing results (61-70 of 905) with videos related to
Sort By:
Pageof 91
Journal of Cardiac Failure|March 25, 2018
Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT TrialAkshay S Desai, Jiankang Liu, Marc A Pfeffer, et al.The New England Journal of Medicine|April 11, 2014
Spironolactone for heart failure with preserved ejection fractionBertram Pitt, Marc A Pfeffer, Susan F Assmann, et al.European Journal of Heart Failure|November 18, 2017
Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trialSenthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.Current Cardiology Reports|June 9, 2004
Eplerenone: will it have a role in the treatment of acute coronary syndromes?David J Meier, Bertram Pitt, Sanjay RajagopalanEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|March 7, 2019
Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developmentsFaiez Zannad, João Pedro Ferreira, Bertram PittCell Metabolism|November 3, 2021
EMPEROR-Preserved: A promise fulfilledDeepak L Bhatt, Subodh Verma, Bertram PittJournal of the American College of Cardiology|February 16, 2018
Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial FibrillationJoão Pedro Ferreira, Nicolas Girerd, John Gregson, et al.Circulation|June 23, 2017
Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)Sheila M Hegde, Brian Claggett, Amil M Shah, et al.JACC. Heart Failure|September 13, 2020
Associations Between Depressive Symptoms and HFpEF-Related OutcomesAlvin Chandra, Michael A D Alcala, Brian Claggett, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 11, 2003
Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular diseaseBertram Pitt, Charles T Stier, Sanjay RajagopalanPageof 91